We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Metrion Biosciences Appoints Mark Keogh as Non-Executive Director

Product News   Apr 19, 2021

 
Metrion Biosciences Appoints Mark Keogh as Non-Executive Director
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R)

Product News

Orgenesis Inc. announces it has been granted Investigational Device Exemption (IDE) approval by the United States Food and Drug Administration (FDA) to conduct a first-in-human feasibility study of the Tissue Genesis Icellator2(R) to treat Acute Respiratory Distress Syndrome (ARDS) resulting from COVID-19 infection.

READ MORE

Lonza Announces Results of the 2021 Annual General Meeting

Product News

Lonza Group Ltd has hosted its Annual General Meeting, led by the Chairman of the Board of Directors, Albert M. Baehny.

READ MORE

Cytel Appoints New VP Scientific Strategy & Innovation To Further Drive Bayesian Innovation

Product News

Cytel Inc. is pleased to announce that renowned Bayesian clinical trial design specialist Dr Kyle Wathen has joined Cytel as Vice President of Scientific Strategy and Innovation.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE